The Ritedose Corporation (Ritedose), a company involved in pharmaceutical development, aseptic cGMP manufacturing and 503B outsourcing solutions, began production of a particular form of Albuterol Sulfate that the FDA has listed in short supply in the U.S. It will be available in May. In March, the U.S. FDA announced a drastic downturn in the nation’s supply of Albuterol Sulfate (0.5% Inhalation Solution). The medication, a breathing treatment for asthma and certain types of chronic obs...